Use of virologic assays in the diagnosis and management of hepatitis C virus infection.
ABSTRACT This article discusses the use of virologic assays in the diagnosis and management of hepatitis C virus (HCV) infection. The use of virologic tests has become essential in the management of HCV infection to diagnose HCV infection, guide treatment decisions, and assess the virologic response to antiviral therapy. The continuing development of test systems accompanied by new antiviral drugs and novel therapeutic approaches should lead to an optimization of the treatment of HCV infection.
SourceAvailable from: Jia-Horng Kao[Show abstract] [Hide abstract]
ABSTRACT: The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the “APASL Consensus Statements and Management Algorithms for Hepatitis C Virus Infection” in December, 2010, in order to revise “Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection (J Gastroenterol Hepatol 22:615–633, 2007)”. The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Makuhari, Chiba, Japan on 19 December 2010. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations are presented in this review.Hepatology International 04/2012; 6(2). DOI:10.1007/s12072-012-9342-y · 2.47 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes as mortality. Sustained viral response is reached in near 50% of patients with the previous management based in pegylated interferon and ribavirin. Recently new drugs were available increasing sustained viral response significantly, changing the standard of care to triple therapy. This guidelines provides a framework for practitioner in Latin America, to the management of patients with hepatitis C chronic infection.Annals of hepatology: official journal of the Mexican Association of Hepatology 03/2013; Mar-Apr(Suppl):3-35. · 2.19 Impact Factor
Gastroenterología y Hepatología 10/2006; 29. DOI:10.1157/13097589 · 0.83 Impact Factor